Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04126200 · BASELINE

Baseline characteristics

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) · Source last updated 2026-05-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      271
    units
    Participants
groups
  1. description
    Participants with Relapsed/Refractory Multiple Myeloma (RRMM) were screened to be randomized in sub-studies of this master protocol.
    id
    BG000
    title
    All Screened Participants
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          8.89
          value
          67.1
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    YEARS
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          122
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          149
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          46
      title
      Asian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          209
      title
      White
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      All Other Races
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Missing
    description
    Race categories (American Indian or Alaska Native and Black or African American) are combined under 'All Other Races' category as the study is evaluating participants with rare disease.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      271
    units
    Participants
groups
  1. description
    Participants with Relapsed/Refractory Multiple Myeloma (RRMM) were screened to be randomized in sub-studies of this master protocol.
    id
    BG000
    title
    All Screened Participants
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          8.89
          value
          67.1
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    YEARS
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          122
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          149
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          46
      title
      Asian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          209
      title
      White
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      All Other Races
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Missing
    description
    Race categories (American Indian or Alaska Native and Black or African American) are combined under 'All Other Races' category as the study is evaluating participants with rare disease.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice